MALARIA,FALCIPARUM
Clinical trials for MALARIA,FALCIPARUM explained in plain language.
Never miss a new study
Get alerted when new MALARIA,FALCIPARUM trials appear
Sign up with your email to follow new studies for MALARIA,FALCIPARUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New malaria vaccine trial aims to protect both adults and kids
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new malaria vaccine in healthy adults (18-35 years) and children (5-17 months) in Burkina Faso. The vaccine combines three parts of the malaria parasite to try to give stronger protection. The main goal is to check if it is safe and how well the immune system r…
Matched conditions: MALARIA,FALCIPARUM
Phase: PHASE1 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:55 UTC
-
New malaria vaccine trial aims to stop parasite in its tracks
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage trial tests a new malaria vaccine (PfSPZ-LARC2) in 58 healthy adults who have never had malaria. The vaccine uses weakened malaria parasites that stop growing in the liver and cannot cause blood infection. Researchers will check safety and whether it protects aga…
Matched conditions: MALARIA,FALCIPARUM
Phase: PHASE1 • Sponsor: Sanaria Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 29, 2026 15:05 UTC
-
New blood test aims to stamp out relapsing malaria in africa
Disease control Recruiting nowThis study tests a new way to fight a type of malaria that can hide in the liver and come back. Researchers will use a simple blood test to find people who have been infected recently, then give them medicine to kill the hidden parasites. About 19,200 people in Ethiopia and Madag…
Matched conditions: MALARIA,FALCIPARUM
Phase: PHASE3 • Sponsor: London School of Hygiene and Tropical Medicine • Aim: Disease control
Last updated May 17, 2026 11:38 UTC
-
Could mass drug administration wipe out malaria in ghanaian communities?
Disease control Recruiting nowThis study aims to see if giving a combination of malaria drugs (DHAP and primaquine) to everyone in high-risk communities can reduce malaria infections and stop the disease from spreading. About 9,000 people aged 3 months and older will receive the drugs every two months for a y…
Matched conditions: MALARIA,FALCIPARUM
Phase: NA • Sponsor: Noguchi Memorial Institute for Medical Research • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New malaria pill enters first human safety tests
Prevention Recruiting nowThis study is the first time a new experimental malaria drug, GSK4024484, is being tested in humans. It aims to check the drug's safety in 156 healthy adults and see how food affects its absorption. Participants will receive either the drug or a placebo, and researchers will moni…
Matched conditions: MALARIA,FALCIPARUM
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: Prevention
Last updated May 14, 2026 12:02 UTC